Loading…
Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1
Purpose To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T). Methods Two hundred fifty‐one h...
Saved in:
Published in: | Acta ophthalmologica (Oxford, England) England), 2022-06, Vol.100 (4), p.454-461 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3 |
container_end_page | 461 |
container_issue | 4 |
container_start_page | 454 |
container_title | Acta ophthalmologica (Oxford, England) |
container_volume | 100 |
creator | Minderhout, Helena M. Joosse, Maurits V. Grootendorst, Diana C. Schalij‐Delfos, Nicoline E. |
description | Purpose
To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T).
Methods
Two hundred fifty‐one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double‐blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax‐K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor.
Results
A linear mixed model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium‐ and dark‐pigmented skin in C + T, −1.02 ± 0.29 (−1.59/−0.45) and −1.53 ± 0.30 (−2.10/−0.95); and in subjects having a light‐, medium‐ and dark‐pigmented skin in C + C, −0.74 ± 0.34 (−1.41/−0.06), −1.26 ± 0.30 (−1.85/−0.66) and −1.84 ± 0.30 (−2.42/−1.26). Similar findings were present for RA. Our model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark‐irided subjects with medium‐ and dark‐pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28).
Conclusions
We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark‐irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark‐irided subjects. |
doi_str_mv | 10.1111/aos.15016 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9298034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2660799533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3</originalsourceid><addsrcrecordid>eNp1kkuL1TAUgIsozkMX_gEJiDAu7kzSNumtC2EYxgcMzEIFdyFNTu7NmCadpB2pP9Ff5fF2vKhgFnl--c4JOUXxjNFThu1MxXzKOGXiQXHIGs5XVSPWD_dz_uWgOMr5hlLBhKgfFwdVLZqSUXpY_Licgejo45SICobkry6QwW16CKMaXQxEZZLdJjjrtAojsUqPMWViYyIJbMKluwMSp1HHHnaOBNmZSXmiNO710SwiFG_nAVIPY4qD00RvnTcJwmuiSMKLsXffwRDtXcBYnozJYT9lFzZEz9rHAZOKXo1A2MtdpEWkemdw60nxyCqf4en9eFx8fnv56eL96ur63YeL86uVrutKrNqO2rVodcWN4l1FteCgjLJdy2vTQNm1lSlL2zVN3XVN11oQXFuOmLG1LqE6Lt4s3mHqejAak0rKyyG5XqVZRuXk3yfBbeUm3sm2bNe0qlFwci9I8XaCPMreZQ3eqwBxyrLka14zxlmD6It_0Bv8qYDPk6UQtGlbXlVIvVoonWLO-Cv7ZBiVvypEYoXIXYUg-_zP7Pfk75JA4GwBvjkP8_9N8vz646L8CTmlzKU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2660799533</pqid></control><display><type>article</type><title>Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1</title><source>Wiley</source><creator>Minderhout, Helena M. ; Joosse, Maurits V. ; Grootendorst, Diana C. ; Schalij‐Delfos, Nicoline E.</creator><creatorcontrib>Minderhout, Helena M. ; Joosse, Maurits V. ; Grootendorst, Diana C. ; Schalij‐Delfos, Nicoline E.</creatorcontrib><description>Purpose
To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T).
Methods
Two hundred fifty‐one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double‐blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax‐K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor.
Results
A linear mixed model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium‐ and dark‐pigmented skin in C + T, −1.02 ± 0.29 (−1.59/−0.45) and −1.53 ± 0.30 (−2.10/−0.95); and in subjects having a light‐, medium‐ and dark‐pigmented skin in C + C, −0.74 ± 0.34 (−1.41/−0.06), −1.26 ± 0.30 (−1.85/−0.66) and −1.84 ± 0.30 (−2.42/−1.26). Similar findings were present for RA. Our model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark‐irided subjects with medium‐ and dark‐pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28).
Conclusions
We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark‐irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark‐irided subjects.</description><identifier>ISSN: 1755-375X</identifier><identifier>EISSN: 1755-3768</identifier><identifier>DOI: 10.1111/aos.15016</identifier><identifier>PMID: 34672100</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Children ; cyclopentolate ; cycloplegics ; dark iris ; hypermetropia ; Iris ; Original ; pigmentation ; residual accommodation ; Skin ; Skin pigmentation</subject><ispartof>Acta ophthalmologica (Oxford, England), 2022-06, Vol.100 (4), p.454-461</ispartof><rights>2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Foundation</rights><rights>2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3</citedby><cites>FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3</cites><orcidid>0000-0002-0154-8815</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34672100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Minderhout, Helena M.</creatorcontrib><creatorcontrib>Joosse, Maurits V.</creatorcontrib><creatorcontrib>Grootendorst, Diana C.</creatorcontrib><creatorcontrib>Schalij‐Delfos, Nicoline E.</creatorcontrib><title>Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1</title><title>Acta ophthalmologica (Oxford, England)</title><addtitle>Acta Ophthalmol</addtitle><description>Purpose
To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T).
Methods
Two hundred fifty‐one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double‐blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax‐K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor.
Results
A linear mixed model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium‐ and dark‐pigmented skin in C + T, −1.02 ± 0.29 (−1.59/−0.45) and −1.53 ± 0.30 (−2.10/−0.95); and in subjects having a light‐, medium‐ and dark‐pigmented skin in C + C, −0.74 ± 0.34 (−1.41/−0.06), −1.26 ± 0.30 (−1.85/−0.66) and −1.84 ± 0.30 (−2.42/−1.26). Similar findings were present for RA. Our model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark‐irided subjects with medium‐ and dark‐pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28).
Conclusions
We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark‐irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark‐irided subjects.</description><subject>Children</subject><subject>cyclopentolate</subject><subject>cycloplegics</subject><subject>dark iris</subject><subject>hypermetropia</subject><subject>Iris</subject><subject>Original</subject><subject>pigmentation</subject><subject>residual accommodation</subject><subject>Skin</subject><subject>Skin pigmentation</subject><issn>1755-375X</issn><issn>1755-3768</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kkuL1TAUgIsozkMX_gEJiDAu7kzSNumtC2EYxgcMzEIFdyFNTu7NmCadpB2pP9Ff5fF2vKhgFnl--c4JOUXxjNFThu1MxXzKOGXiQXHIGs5XVSPWD_dz_uWgOMr5hlLBhKgfFwdVLZqSUXpY_Licgejo45SICobkry6QwW16CKMaXQxEZZLdJjjrtAojsUqPMWViYyIJbMKluwMSp1HHHnaOBNmZSXmiNO710SwiFG_nAVIPY4qD00RvnTcJwmuiSMKLsXffwRDtXcBYnozJYT9lFzZEz9rHAZOKXo1A2MtdpEWkemdw60nxyCqf4en9eFx8fnv56eL96ur63YeL86uVrutKrNqO2rVodcWN4l1FteCgjLJdy2vTQNm1lSlL2zVN3XVN11oQXFuOmLG1LqE6Lt4s3mHqejAak0rKyyG5XqVZRuXk3yfBbeUm3sm2bNe0qlFwci9I8XaCPMreZQ3eqwBxyrLka14zxlmD6It_0Bv8qYDPk6UQtGlbXlVIvVoonWLO-Cv7ZBiVvypEYoXIXYUg-_zP7Pfk75JA4GwBvjkP8_9N8vz646L8CTmlzKU</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Minderhout, Helena M.</creator><creator>Joosse, Maurits V.</creator><creator>Grootendorst, Diana C.</creator><creator>Schalij‐Delfos, Nicoline E.</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0154-8815</orcidid></search><sort><creationdate>202206</creationdate><title>Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1</title><author>Minderhout, Helena M. ; Joosse, Maurits V. ; Grootendorst, Diana C. ; Schalij‐Delfos, Nicoline E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Children</topic><topic>cyclopentolate</topic><topic>cycloplegics</topic><topic>dark iris</topic><topic>hypermetropia</topic><topic>Iris</topic><topic>Original</topic><topic>pigmentation</topic><topic>residual accommodation</topic><topic>Skin</topic><topic>Skin pigmentation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Minderhout, Helena M.</creatorcontrib><creatorcontrib>Joosse, Maurits V.</creatorcontrib><creatorcontrib>Grootendorst, Diana C.</creatorcontrib><creatorcontrib>Schalij‐Delfos, Nicoline E.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta ophthalmologica (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Minderhout, Helena M.</au><au>Joosse, Maurits V.</au><au>Grootendorst, Diana C.</au><au>Schalij‐Delfos, Nicoline E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1</atitle><jtitle>Acta ophthalmologica (Oxford, England)</jtitle><addtitle>Acta Ophthalmol</addtitle><date>2022-06</date><risdate>2022</risdate><volume>100</volume><issue>4</issue><spage>454</spage><epage>461</epage><pages>454-461</pages><issn>1755-375X</issn><eissn>1755-3768</eissn><abstract>Purpose
To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T).
Methods
Two hundred fifty‐one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double‐blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax‐K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor.
Results
A linear mixed model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium‐ and dark‐pigmented skin in C + T, −1.02 ± 0.29 (−1.59/−0.45) and −1.53 ± 0.30 (−2.10/−0.95); and in subjects having a light‐, medium‐ and dark‐pigmented skin in C + C, −0.74 ± 0.34 (−1.41/−0.06), −1.26 ± 0.30 (−1.85/−0.66) and −1.84 ± 0.30 (−2.42/−1.26). Similar findings were present for RA. Our model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark‐irided subjects with medium‐ and dark‐pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28).
Conclusions
We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark‐irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark‐irided subjects.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34672100</pmid><doi>10.1111/aos.15016</doi><tpages>461</tpages><orcidid>https://orcid.org/0000-0002-0154-8815</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1755-375X |
ispartof | Acta ophthalmologica (Oxford, England), 2022-06, Vol.100 (4), p.454-461 |
issn | 1755-375X 1755-3768 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9298034 |
source | Wiley |
subjects | Children cyclopentolate cycloplegics dark iris hypermetropia Iris Original pigmentation residual accommodation Skin Skin pigmentation |
title | Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A58%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eye%20colour%20and%20skin%20pigmentation%20as%20significant%20factors%20for%20refractive%20outcome%20and%20residual%20accommodation%20in%20hypermetropic%20children:%20a%20randomized%20clinical%20trial%20using%20cyclopentolate%201%25%20and%20tropicamide%201&rft.jtitle=Acta%20ophthalmologica%20(Oxford,%20England)&rft.au=Minderhout,%20Helena%20M.&rft.date=2022-06&rft.volume=100&rft.issue=4&rft.spage=454&rft.epage=461&rft.pages=454-461&rft.issn=1755-375X&rft.eissn=1755-3768&rft_id=info:doi/10.1111/aos.15016&rft_dat=%3Cproquest_pubme%3E2660799533%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2660799533&rft_id=info:pmid/34672100&rfr_iscdi=true |